FDA NDC Directory · JSON-LD · Markdown

BAVENCIO

NDC 44087-3535 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameavelumab
Labeler / ManufacturerEMD Serono, Inc.
Marketing categoryBiologic License Application · App BLA761049
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsAVELUMAB (20 mg/mL)
Marketing started20170323
Package count1

External sources

Source: openFDA. Public-domain (CC0).